Parents' preferences for follow-up care in a type 1 diabetes paediatric population: a survey-based study in Quebec,

Maude Laberge1,2, Monia Rekik3, Kodjo Mawuegnigan Djiffa3

  • 1Operations and Decision Systems, Universite Laval Faculte des sciences de l'administration, Quebec, Quebec, Canada maude.laberge@fsa.ulaval.ca.

BMJ Open
|November 26, 2021
PubMed

Insights

Many parents of children with type 1 diabetes (T1D) prefer longer intervals between endocrinology appointments than guidelines suggest. Parental experience with T1D management influences preferences for follow-up care intensity.

Area of Science:

  • Pediatric Endocrinology
  • Health Services Research
  • Patient-Centered Care

Background:

  • Clinical guidelines recommend quarterly endocrinology follow-up for pediatric type 1 diabetes (T1D) management.
  • Parental preferences for T1D care intensity may vary and potentially deviate from established guidelines.
  • Understanding these preferences is crucial for optimizing patient and family-centered care delivery.

Purpose of the Study:

  • To investigate parental preferences regarding the frequency of follow-up appointments for their children with T1D.
  • To identify factors influencing parents' desired intensity of T1D care.
  • To explore potential deviations from standard 3-month follow-up intervals.

Main Methods:

  • A survey was developed in collaboration with a patient-partner to gather data from parents of children with T1D in Quebec, Canada.
  • The primary outcome measured was the preferred time interval (in months) between appointments.
  • A probit model was used to analyze preferences for longer intervals (over 3 months) versus standard care (≤3 months).

Main Results:

  • Approximately one-third (33%) of parents expressed a desire to extend the time between appointments beyond the recommended 3 months.
  • Increased parental experience in managing T1D and higher perceived costs were associated with preferring longer intervals.
  • Longer duration since diagnosis correlated positively with a preference for spaced-out appointments, while perceived information utility and professional life changes correlated negatively.

Conclusions:

  • Parental preferences for T1D follow-up care frequency can differ from clinical guidelines.
  • Factors such as disease management experience and perceived value of consultations influence these preferences.
  • Tailoring visit protocols to align with patient and parent needs could enhance healthcare system efficiency for T1D care.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.5K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
451
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
302
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.2K
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
100
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.2K